Journal

What a considered aesthetic consultation involves

A considered aesthetic consultation looks beyond one line or feature. It brings together whole-face anatomy, the changes you have noticed, your priorities, relevant medical history and realistic limits, before considering whether any approach is appropriate for you.

Dr Souphi Samizadeh 2026-09-11 9 min read
Editorial clinical portrait of an adult patient with subtle whole-face assessment markers showing skin, muscle, fat, supporting structures and facial skeleton.

At a glance

What the evidence supports

Facial change is layered and individual

Facial shape reflects interconnected skin, muscle, fat, supporting structures and bone. Changes over time can affect these layers differently between people and across areas of the face.

Sources N1 N2

Appropriateness depends on context

A consultation considers what matters to you, the change you hope for, medical history, expectations and whether an approach is appropriate. No procedure, another option or a second opinion may be more appropriate.

Sources N3

Outcomes and risks require individual discussion

Filler durability and appearance vary by product, placement, area, amount, tissue behaviour, follow-up and the individual. Filler also has uncommon but potentially serious injection-specific vascular risks.

Sources N5 N6

Starting with the whole face

Assessment begins beyond a single feature

A considered facial assessment starts with layers, not a single line or feature. Skin, muscle, fat, supporting structures and the facial skeleton all contribute to facial shape.

Changes over time are three-dimensional and individual. They can involve skin quality, fat distribution, soft-tissue support and skeletal remodelling, so a consultation should not assume that every hollow, fold or loss of definition has the same cause.

The conversation should establish what you have noticed, what matters to you, the change you hope for, relevant medical history, and whether any proposed approach is appropriate for your needs.

  • Facial shape reflects several interconnected layers.
  • The same visible concern can have different contributing factors.
  • Your priorities and relevant context are part of assessment.

Evidence note: Evidence describes facial ageing as an interacting, three-dimensional process. Professional standards support an individual discussion of concerns, goals, medical history and appropriateness. N1 N2 N3

Whole-face assessment considers interconnected facial layers.

Why context matters

A photograph cannot make the plan

Facial contouring cannot be responsibly planned from a photograph, trend or one isolated feature. Assessment of the whole face, medical context and individual anatomy matters. Adding volume is not automatically the right response to laxity, surface change or movement-related lines.

A consultation should also consider expectations, whether a request is voluntary, psychological needs, and the physical and psychological consequences if a cosmetic intervention goes wrong or does not meet expectations. These are parts of informed decision-making, not assumptions about any individual.

  • An isolated feature does not explain the whole face.
  • Individual anatomy and medical context matter.
  • Expectations and voluntariness belong in the discussion.

Evidence note: Evidence supports whole-face, individual assessment rather than planning from an image or trend. Cosmetic-intervention guidance also requires attention to voluntariness, vulnerabilities and possible physical and psychological consequences. N1 N3

A patient-free editorial comparison showing an isolated facial-area outline beside a whole-face assessment map with context notes.
Isolated concern
A patient-free editorial comparison showing an isolated facial-area outline beside a whole-face assessment map with context notes.
Whole-face context
Whole-face context is different from an isolated concern.

Understanding the discussion

Contouring is a planning framework

Facial contouring is a planning framework rather than one universal procedure. It considers proportion and the relationship between areas of the face, then asks whether the concern is principally volume, definition, movement, surface quality, tissue support, or a combination.

Dermal filler may be discussed when a clinician judges that selected areas may benefit from support, proportion or definition. It is an injectable implant material, not a universal lifting treatment, and product choice, tissue plane, amount and area require individual clinical judgement.

A prescribed skincare plan can be a supporting part of facial assessment when the priority is skin quality or photodamage rather than structural change. Evidence for an ingredient does not prove that every product marketed as “medical grade” will give the same effect.

Where a clinician considers treatment for movement-related lines, the consultation should assess the pattern of movement, facial balance, relevant medical factors, likely limitations and risks. It should not promise a fixed expression, an outcome or suitability.

  • Volume, definition, movement, surface quality and support may overlap.
  • Filler is a selected-area option, not a universal lifting treatment.
  • Skin quality and movement-related lines need their own assessment.

Evidence note: Facial contouring is described as an individual planning framework. Evidence supports topical tretinoin for specific signs of facial photodamage, but ingredient evidence does not establish the same effect for every product marketed as “medical grade”. N1 N3 N4 N5 N6 N7 N8 N10

Editorial whole-face diagram with sparse labels for volume, definition, movement, surface quality and tissue support, plus notes that selected-area filler, skincare and movement assessment require individual judgement.
Assessment considers relationships between facial concerns.

Keeping choices open

Appropriate options may differ

A good consultation includes the possibility that no procedure, a different option, or a second opinion is more appropriate. It should distinguish a realistic improvement from an exact or guaranteed result.

Before deciding, patients need clear information about material risks, alternatives, expected limitations, follow-up requirements and the potential consequences if treatment does not meet expectations. The clinician performing or supervising the procedure is responsible for the consent discussion.

  • Treatment is not the only appropriate outcome of a consultation.
  • Realistic improvement is different from an exact or guaranteed result.
  • Risks, alternatives, limitations and follow-up should be clear before deciding.

Evidence note: Professional standards require discussion of likely benefit, alternatives, limitations, risks, follow-up and the option of a second opinion, alongside a clinician-led consent discussion. N3

Patient-free assessment aid showing treatment, another option, no procedure and second opinion alongside risks, alternatives, limitations and follow-up.
A consultation can identify several clinically neutral possibilities.

Reflection and safeguards

Consent allows time to think

A consultation is not a commitment to treatment. You should have the time and information needed to reflect, and you can change your mind at any point.

Filler consultations must include injection-specific risks. Intravascular injection and vascular occlusion are uncommon but potentially serious complications; delayed recognition can cause tissue injury, and visual loss or stroke are possible catastrophic outcomes. This is why anatomical knowledge, prevention, recognition and an emergency pathway matter.

The durability and appearance of filler cannot be promised in a general consultation asset. They vary with the product, placement, area, amount, tissue behaviour, follow-up and the individual.

Active skincare can cause irritation and may increase sun sensitivity. Product choice, introduction schedule, tolerability, skin condition and sun protection should be considered individually. Prescription-only medicines must not be advertised to the general public.

  • Reflection and changing your mind are part of voluntary consent.
  • Filler has uncommon but potentially serious injection-specific vascular risks.
  • Filler results vary, and active skincare needs individual consideration.

Evidence note: Guidance supports time for reflection and the right to change your mind. Filler-specific vascular complications are uncommon but potentially serious. Filler durability varies individually. Active skincare can cause irritation and increased sun sensitivity. N3 N5 N6 N8 N9

Patient-free disclosure aid with panels for time to reflect, changing your mind, injection-specific vascular risk preparation, variable filler appearance and durability, and skincare irritation and sun sensitivity.
Reflection, uncertainty and risk discussion are safeguards.

An informed next step

Education before promotion

Public information should support education or a consultation-led enquiry, where questions and individual assessment can guide the next conversation. It should not reduce a personal decision to a product-led message.

For public educational material, use a consultation, enquiry or educational destination rather than a route that promotes a prescription-only medicine or named prescription product.

  • Public education can explain principles without deciding what is appropriate for you.
  • Questions and individual assessment matter.
  • Prescription-only medicines and named prescription products should not be promoted in public educational material.

Evidence note: Professional standards support individual assessment of needs, goals, medical history and appropriateness. Public educational material must not promote prescription-only medicines or named prescription products. N3 N9

Patient-free editorial recap with calm panels for anatomy, individual assessment, options, limitations and informed reflection.
Education and individual assessment come before product promotion.

Ready for a more considered consultation?

A consultation can help determine what is relevant to you.